tsh biopharmoration Ltd (8432) — Capital Reinvestment Ratio
tsh biopharmoration Ltd (8432) has a Capital Reinvestment Ratio of 0.08x as of June 2025, meaning it reinvests 0% of its operating cash flow (NT$42.55 Million) in capital expenditures (NT$3.27 Million). Check tsh biopharmoration Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
tsh biopharmoration Ltd Capital Reinvestment Ratio (2017–2024)
This chart tracks tsh biopharmoration Ltd's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see tsh biopharmoration Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for tsh biopharmoration Ltd (2017–2024)
Year-by-year Capital Reinvestment Ratio for tsh biopharmoration Ltd from 2017 to 2024. See free cash flow generation of tsh biopharmoration Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | NT$183.77 Million | NT$2.74 Million | ▼ -90.9% |
| 2023 | 0.16x | NT$33.87 Million | NT$5.56 Million | ▼ -69.9% |
| 2022 | 0.55x | NT$34.35 Million | NT$18.73 Million | ▲ +9706.2% |
| 2021 | 0.01x | NT$68.71 Million | NT$382.00K | ▼ -97.3% |
| 2020 | 0.20x | NT$11.61 Million | NT$2.38 Million | ▲ +506.0% |
| 2019 | 0.03x | NT$88.65 Million | NT$3.00 Million | ▼ -64.0% |
| 2018 | 0.09x | NT$62.62 Million | NT$5.88 Million | ▲ +66.8% |
| 2017 | 0.06x | NT$81.13 Million | NT$4.57 Million | — |